Resources from the same session
Considerations for immunotherapy in 1L advanced NSCLC
Presenter: Solange Peters
Session: Regeneron - Current approaches and future strategies in non-oncogene driven advanced NSCLC
Resources:
Webcast
Monotherapy vs. combination therapy treatment considerations
Presenter: Marina Garassino
Session: Regeneron - Current approaches and future strategies in non-oncogene driven advanced NSCLC
Resources:
Webcast
Panel discussion
Session: Regeneron - Current approaches and future strategies in non-oncogene driven advanced NSCLC
Resources:
Webcast